Japan· JP-4291047F2022
トラメチニブ ジメチルスルホキシド付加物
A medicinal product containing トラメチニブ ジメチルスルホキシド付加物, registered in Japan by ノバルティス ファーマ, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- トラメチニブ ジメチルスルホキシド付加物
- Manufacturer
- ノバルティス ファーマ
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
トラメチニブ ジメチルスルホキシド付加物 in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomMekinist 0.5mg tabletsNovartis Pharmaceuticals UK Ltd
- SwitzerlandMekinist 0.5 mg, FilmtablettenNovartis Pharma Schweiz AG
- SpainMEKINIST 0,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULANovartis Europharm Limited
- NetherlandsMekinist 0,5 mg filmomhulde tabletNovartis Europharm Limited
- SwedenMekinist 0,5 mg Filmdragerad tablettNovartis Europharm Limited
- IrelandMekinist 0.5 mg film-coated tabletsNovartis Europharm Limited
- IcelandMekinistNovartis Europharm Limited*
- CanadaMEKINISTNOVARTIS PHARMACEUTICALS CANADA INC
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Mekinist, Spexotras
- Liechtenstein · Mekinist, Spexotras
- Norway · Mekinist, Spexotras
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f94ce394-82aa-47c0-9761-c6a062222f91 GET /v1/drugs/f94ce394-82aa-47c0-9761-c6a062222f91?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "２ｍｇ１錠",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "4291047F2022",
"category": "内用薬",
"price_yen": 31970.7,
"generic_name": "トラメチニブ ジメチルスルホキシド付加物",
"product_name_jp": null,
"therapeutic_class": "4291",
"transitional_expiry": null
}See everything about トラメチニブ ジメチルスルホキシド付加物.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.